Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma
Figure 11.Verification of hub ERGs expression in LUAD and normal lung tissue using the HPA database. (A) ARRB1, (B) PARP1, (C) PKM, (D) TFDP1, (E) YWHAZ.